Skip to main content
. 2022 Sep 2;2022(9):CD012337. doi: 10.1002/14651858.CD012337.pub2
GRADE criteria Risk of bias Publication bias Imprecision Inconsistency Indirectness
Item assessed for algorithm Blinding of outcome assessor Allocation concealment Differential attrition ROBIS domain 2 CIs + sample sizea Heterogeneity, using I2 statisticb Clinical heterogeneity
No downgrade < 50% of participants are from trials with high risk of bias for this domain. < 50% of participants are from trials with high risk of bias for this domain. Chi2 testc, P ≥ 0.05
OR (if baseline participant numbers not available) < 50% participants are from trials with high risk of bias for differential attrition/loss to follow‐up.
Low or unclear risk of bias on ROBIS domain 2 If 95% CI excludes an RR of 1.0, or an MD of 0 I2 ≤ 50% Data from participants with SUI and UUI is not combined.
AND
data from women who are antenatal and postnatal are not combined.
1 downgrade ≥ 50% of participants are from trials with high risk of bias for this domain. ≥ 50% of participants are from trials with high risk of bias for this domain. YES differential attrition – Chi2 testc, P < 0.05
OR (if baseline participant numbers not available) ≥ 50% participants are from trials with high risk of bias for differential attrition/loss to follow‐up.
High risk of bias on ROBIS domain 2 If 95% CI includes an RR of 1.0, or an MD of 0
AND
sample size < 344
I2 > 50% If data from participants with SUI and participants with UUI are combined
OR
if data from women who are antenatal and postnatal (as defined by review authors) are combined
OR
both.
2 downgrades If 95% CI includes an RR of 1.0, or an MD of 0
AND
sample size < 258
I2 > 75%
CI: confidence interval; MD: mean difference; ROBIS: Risk of Bias In Systematic Reviews assessment tool; RR: risk ratio; SUI: stress urinary incontinence; UUI: urgency urinary incontinence.